Search

Issue
Title
Authors
Noninterventional studies of depot formulations of LHRH analogues for prostate cancer in routine clinical practice. The launch of an observational program to assess the use of Eligard 45 mg in Russia
Matveev V.B., Markova A.S.
Buserelin-depot in the treatment of prostate cancer
Kolesnikov G.P.
Luteinizing hormone-releasing hormone agonists for prostate cancer patients: routine clinical practice of Russian cancer urologists
Matveev V.B., Alekseev B.Y., Kamolov B.S., Markova A.S.
CHEMOTHERAPY FOR HORMONE REFRACTORY PROSTATE CANCER
Gridneva Y.V., Matveev V.B., Bukharkin B.V., Kupchan D.Z.
HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION OF PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER
Shaplygin L.V., Solovov V.A., Vozdvizhenskiy M.O., Matyash Y.S., Khametov R.Z., Fesenko D.V.
Long-term outcomes of hypofractionated radiation therapy in patients with high risk prostate cancer
Bulychkin P.V., Ekaterinushkin D.A., Tkachev S.I., Khachaturyan A.V., Nayanov G.B., Ladyko D.D., Selezneva T.D.
Pathologic response to neoadjuvant therapy of high risk prostate cancer
Berkut M.V., Artemjeva A.S., Tolmachev S.S., Reva S.A., Petrov S.V., Nosov A.K.
EFFICIENCY OF HORMONE THERAPY WITH LEIPRORELIN (LUCRIN DEPOT®) IN PATIENTS WITH PROSTATE CANCER
Alekseev B.Y., Kaprin A.D., Nyushko K.M.
INTERMITTENT HORMONE THERAPY IN PATIENTS WITH PROSTATE CANCER
Alekseyev B.Y., Nyushko K.M.
ANDROGEN DEPRIVATION THERAPY WITH LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONISTS FOR PROSTATE CANCER: BEST DISEASE CONTROL WITH A LOWER RISK OF SIDE EFFECTS. RESULTS OF ANALYSIS OF 6 COMPARATIVE RANDOMIZED PHASE III TRIALS OF DEGARELIX AND LUTEINIZIN
Markova A.S., Matveev V.B.
Androgen deprivation therapy and cardiological risks in patients with prostate cancer. Are all drugs the same?
Alekseev B.Y., Perepukhov V.M., Nyushko K.M., Poltavskaya M.G.
Intermediate results of the observational program on the Eligard (45 mg) administration in the clinical practice
Matveev V.B., Markova A.S.
Combined radiotherapy and hormone therapy in unfavorable intermediate risk prostate cancer
Makarova K.S., Gumenetskaya Y.V., Biryukov V.A., Rodina T.A., Galitsyna A.B., Shchukina E.O., Karyakin O.B., Ivanov S.A., Kaprin A.D.
New possibilities of combined antiandrogen therapy in patients with metastatic hormone-sensitive prostate cancer
Alekseev B.Y.
EFFICACY OF ZOLEDRONIC ACID IN THE PREVENTION OF BONE METASTASES IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER
Musaev T.N., Zeinalov R.S., Kerimov A.K., Guliev F.A., Musaev I.N., Alizade A.M., Adzhalov O.V.
The National Registry of treatment regimens in patients with metastatic castration-resistant prostate cancer in the Russian Federation
Karyakin O.B., Kaprin A.D., Ivanov S.A.
HORMONE REFRACTORY PROSTATE CANCER AND ITS DEVELOPMENT DURING ANTIANDROGEN THERAPY
Rakul S.A., Galimov R.D.
An observational multicenter study to evaluate the efficacy and safety of degarelix® for prostate cancer in routine clinical practice
Nyushko K.M., Alekseev B.Y., Perepukhov V.M., Shevchuk I.M., Atduev V.A., Zdobnikov А.B., Venskel V.B., Gurin Е.V., Eremenko A.V., Belov I.V., Gavrilova V.D., Ismakov R.M., Prokhorov D.G., Nikitin R.V., Usinin E.A., Kopyltsov E.I., Leonov O.V., Leonov А.O.
NEW TREATMENT STANDARD FOR PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Alekseev B.Y.
INTERMITTENT HORMONE THERAPY IN PATIENTS WITH PROSTATE CANCER
Alekseyev B.Y., Nyushko K.M.
DIAGNOSIS AND TREATMENT OF METACHRONOUS TESTICULAR CANCER: A CLINICAL CASE
Kalpinsky A.S., Pryadilova E.V., Kaprin A.D., Alekseev B.Y.
Cardiovascular safety of hormone therapy for prostate cancer
Andreev D.A., Zavyalov A.A.
COMPARATIVE ANALYSIS OF THE RESULTS OF CONTINUOUS AND INTERMITTENT HORMONE THERAPY FOR DISSEMINATED PROSTATE CANCER
Babaev E.R., Matveev V.B., Volkova M.I.
Current approaches to selection of the 1st line therapy in patients with metastatic hormone-sensitive prostate cancer
Alekseev B.Y., Andrianov A.N., Kaprin A.D.
Adjuvant hormone therapy in patients undergoing high-intensity focused ultrasound therapy for locally advanced prostate cancer
Neimark A.I., Tachalov M.A., Neimark B.A.
THE POSSIBILITIES AND MECHANISMS OF ACTION OF HORMONE THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER
Alekseev B.Y., Andrianov A.N.
Diferelin® as an effective chemical castration agent for patients with prostate cancer
Nyushko K.M., Perepukhov V.M., Alekseev B.Y.
Efficiency of application of radiation techniques to treat patients with localized prostate cancer in one hospita
Kipriyanov E.A., Karnaukh P.A., Vazhenin I.A., Sharabura T.M., Vazhenin A.V., Ivakhno K.Y.
COMBINATION THERAPY FOR PROSTATE CANCER: CLINICAL OBSERVATIONS
Alekseev B.Y., Nyushko K.M.
INTERMITTENT HORMONE THERAPY WITH ELIGARD IN PATIENTS WITH PROSTATE CANCER
Alekseev B.Y., Krasheninnikov A.A., Nyushko K.M., Kalpinsky A.S., Kaprin A.D.
1 - 30 of 30 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"